Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-23
DOI
10.3389/fneur.2018.00569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behavioural changes in patients with intellectual disability treated with brivaracetam
- (2018) E. Andres et al. ACTA NEUROLOGICA SCANDINAVICA
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview
- (2018) Laurent M. Willems et al. EPILEPSY & BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
- (2018) Felix Zahnert et al. Frontiers in Neurology
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
- (2017) Ingrid E. Scheffer et al. EPILEPSIA
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals
- (2017) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey
- (2017) Bernhard J. Steinhoff et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence
- (2017) Laurent M. Willems et al. Expert Review of Clinical Pharmacology
- The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data
- (2017) Adam Strzelczyk et al. Frontiers in Neurology
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Cannabidiol in patients with treatment-resistant epilepsy – Authors' reply
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy
- (2016) Prisca R Bauer et al. LANCET NEUROLOGY
- Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
- (2016) Elinor Ben-Menachem et al. NEUROLOGY
- Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
- (2016) Adam Strzelczyk et al. Expert Review of Clinical Pharmacology
- Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats
- (2015) Nina Dupuis et al. EPILEPSIA
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam augments short-term depression and slows vesicle recycling
- (2015) Xiaofeng Yang et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy
- (2015) Jacqueline A. French et al. NEUROLOGY
- Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
- (2015) Adam Strzelczyk et al. Expert Review of Clinical Pharmacology
- Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
- (2014) Isabelle Niespodziany et al. CNS Neuroscience & Therapeutics
- First clinical experiences with perampanel-The Kork experience in 74 patients
- (2014) Bernhard J. Steinhoff et al. EPILEPSIA
- Treatment of Epileptic Encephalopathies
- (2013) Amy McTague et al. CNS DRUGS
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation
- (2013) Jan Novy et al. EPILEPSY RESEARCH
- Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: A multicentre study in epilepsy clinics in the United Kingdom (UK)
- (2012) Lorena Flores et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre
- (2011) Claudia B. Catarino et al. EPILEPSY RESEARCH
- Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study
- (2010) G. Kluger et al. ACTA NEUROLOGICA SCANDINAVICA
- Measuring outcomes of treatment with antiepileptic drugs in clinical trials
- (2010) Elinor Ben-Menachem et al. EPILEPSY & BEHAVIOR
- Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome
- (2010) G. Coppola et al. EUROPEAN JOURNAL OF NEUROLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
- (2008) T. Glauser et al. NEUROLOGY
- Clinical efficacy of zonisamide in Lennox–Gastaut syndrome: Korean multicentric experience
- (2007) Su Jeong You et al. BRAIN & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now